4,0
13 ott 2017
Dipendente anonimo
Dipendente attuale
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Autonomy in the field, good therapies,
Svantaggi
Poor marketing materials, managers have their favorites, many people still do not know who Actelion is, hoping the J and J acquisition will help change this.